# Neural Conduction Along the Visual Pathways After Oral Treatment With Citicoline in Patients With Optic Nerve Diseases

> **NCT00404729** · PHASE4 · COMPLETED · sponsor: **Fondazione G.B. Bietti, IRCCS** · enrollment: 60 (actual)

## Conditions studied

- Glaucoma
- Optic Neuropathy, Ischemic
- Visual Pathway Disorder
- Optic Nerve
- Neural Conduction

## Interventions

- **DRUG:** Citicoline

## Key facts

- **NCT ID:** NCT00404729
- **Lead sponsor:** Fondazione G.B. Bietti, IRCCS
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02-28
- **Primary completion:** 2006-02-28
- **Final completion:** 2006-07-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00404729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00404729, "Neural Conduction Along the Visual Pathways After Oral Treatment With Citicoline in Patients With Optic Nerve Diseases". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00404729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*